AstraZenecas Lynparza Cleared in U.S. for Ovarian Cancer
The drug was approved in the EU as a monotherapy for the maintenance treatment of adults suffering from platinum sensitive relapsed BRCA-mutated high grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in complete or ...
Zacks.com - Mon, 22 Dec 2014 13:45



Kenyan Women With HIV Are Suing Hospitals and Aid Organizations Over ...
The sterilizations occurred via tubal ligation, a surgical procedure that permanently prevents a woman's fallopian tubes from delivering eggs to her uterus. The incidents allegedly took place at six major medical facilities, including ... According to ...
VICE News - Sun, 21 Dec 2014 07:33



If Laparoscopic Power Morcellation Is Unsafe, Why Does the FDA Allow It?
Yet another report, appearing online December 5 in Obstetrics & Gynecology, chronicles the experiences of three women who battled benign uterine disease - including massive tumor growth - following what many now characterize as one of the dangerous ...
LawyersandSettlements.com - Sun, 21 Dec 2014 07:56



Does New 'Grey's Anatomy' Storyline Raise Questions About When A Baby's Life ...
However, her Fallopian tube burst, threatening her life and the baby couldn't be saved. The abortion she had was a ... There are up to eight types of the disease and the Kepner/Avery baby was diagnosed with the most severe type, type 2. As the ...
The Inquisitr - Sat, 20 Dec 2014 17:30

AstraZenecas Lynparza Approved in EU for Ovarian Cancer
The European Commission (EC) approved AstraZeneca's (AZN - Analyst Report) Lynparza as a monotherapy for the maintenance treatment of adults suffering from platinum sensitive relapsed BRCA-mutated high grade serous epithelial ovarian, fallopian tube or ...
Zacks.com - Fri, 19 Dec 2014 12:48

AstraZeneca's Lynparza Approved in EU for Ovarian Cancer - Analyst Blog
Lynparza as a monotherapy for the maintenance treatment of adults suffering from platinum sensitive relapsed BRCA-mutated high grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in complete or partial response to ...
Nasdaq - Fri, 19 Dec 2014 12:48



Cancer survival rates higher than ever, says report
Ireland has the worst survival rates in Europe for cancer of the ovaries and fallopian tubes, and below average rates for cervical, breast and stomach cancer. The incidence of lung cancer is falling among men but rising among women, reflecting changing ...
Irish Times - Wed, 17 Dec 2014 23:00



Life-extending ovarian cancer drug approved by European Union
It will be given to women with "high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete response or partial response to platinum-based chemotherapy". The drug is ... In 2012, 4,271 women died from the disease.
International Business Times UK - Thu, 18 Dec 2014 04:22


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014